Cancer researchers at Children’s Hospital of Philadelphia (CHOP) have harnessed tools used for the development of cancer immunotherapies and adapted them to identify regions of the SARS-CoV-2 virus to target with a vaccine, employing the same approach used to elicit an immune response against cancer cells to stimulate an immune response against the virus. Using this strategy, the researchers believe a resulting vaccine would provide protection across the human population and drive a long-term immune response.
- Tissue, scaffold technologies provide new options for breast cancer, other diseases
- High fat diets may over-activate destructive heart disease protein
- A materials science approach to combating coronavirus
- New study proposes a low cost, high efficiency mask design
- Coffee for the birds: connecting bird-watchers with shade-grown coffee